Halozyme Therapeutics EBIT 2010-2024 | HALO
- Halozyme Therapeutics 2023 EBIT was 0.338B, a 26.18% increase from 2022.
- Halozyme Therapeutics 2022 EBIT was 0.268B, a 3.03% decline from 2021.
- Halozyme Therapeutics 2021 EBIT was 0.276B, a 91.26% increase from 2020.
EBIT can be defined as earnings before interest and taxes.